Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Solid Tumors|Breast Cancer|Non-small Cell Lung Cancer|Prostate Cancer|Gastric Cancer
Interventions: DRUG: Docetaxel|DRUG: Sunitinib
Sponsor: National University Hospital, Singapore